Delivery Order SPE2DB24D2101-SPE2DB25FKJJF
Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $11,420.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 22, 2025. It is not designated as a set-aside contract, indicating open...
- This federal contract award, valued at $11,367.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 16, 2025. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award, valued at $5,940.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite...
- This federal contract award, valued at $11,631.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used for treating and preventing blood clots. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of May 5, 2025. It is not designated as a set-aside contract, indicating...
- This federal contract award, valued at $12,995.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 9, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $43,013.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $1,883.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The award is not set-aside and represents open competition. AmerisourceBergen Drug...
- This federal contract award, valued at $55,833.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2025. The award is not set-aside and was competitively issued. AmerisourceBergen Drug...
- This federal contract award, valued at $7,471.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of January 17, 2025 and is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- This federal contract award is a delivery order valued at $11,984.53 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Eliquis 5 mg tablets, a prescription medication used to treat and prevent blood clots. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...